Be a Smart Investor
Monday, January 22, 2018
Small- and mid-cap stocks the place to play in biotech: Analyst
Jefferies' Michael Yee discusses the big deals in biotech, like Celgene's acquisition of Juno Therapeutics, and what means for the rest of the sector.
from Mergers and Acquisitions http://ift.tt/2DxwEWp
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment